Publications

Witeof AE, Meinerz NM, Walker KD, Funke HH, Garcea RL, Randolph TW. A Single Dose, Thermostable, Trivalent Human Papillomavirus Vaccine Formulated Using Atomic Layer Deposition. J Pharm Sci. 2023 Aug;112(8):2223-2229.

Dong M, Meinerz NM, Walker KD, Garcea RL, Randolph TW. Thermostability of a trivalent, capsomere-based vaccine for human papillomavirus infection. Eur J Pharm Biopharm. 2021 Nov;168:131-138. doi: 10.1016/j.ejpb.2021.08.008. Epub 2021 Aug 23. 

Peters DK, Erickson KD, Garcea RL. Live Cell Microscopy of Murine Polyomavirus Subnuclear Replication Centers. Viruses. 2020 Oct 2;12(10):1123. doi: 10.3390/v12101123. 

Garcea RL, Meinerz NM, Dong M, Funke H, Ghazvini S, Randolph TW. Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology. NPJ Vaccines. 2020 Jun 2;5(1):45. doi: 10.1038/s41541-020-0195-4. 

Peters DK, Garcea RL. Murine polyomavirus DNA transitions through spatially distinct nuclear replication subdomains during infection. PLoS Pathog. 2020 Mar 23;16(3):e1008403. doi: 10.1371/journal.ppat.1008403. 

Erickson KD, Garcea RL. Viral replication centers and the DNA damage response in JC virus-infected cells. Virology. 2019 Feb;528:198-206. doi: 10.1016/j.virol.2018.12.014. 

O'Hara SD, Garcea RL. Murine Polyomavirus Cell Surface Receptors Activate Distinct Signaling Pathways Required for Infection. mBio. 2016 Nov 1;7(6):e01836-16. doi: 10.1128/mBio.01836-16. 

Heiser K, Nicholas C, Garcea RL. Activation of DNA damage repair pathways by murine polyomavirus. Virology. 2016 Oct;497:346-356. doi: 10.1016/j.virol.2016.07.028. Epub 2016 Aug 16. 

You J, O'Hara SD, Velupillai P, Castle S, Levery S, Garcea RL, Benjamin T. Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus. PLoS Pathog. 2015 Oct 16;11(10):e1005175. doi: 10.1371/journal.ppat.1005175. 

Buch MH, Liaci AM, O'Hara SD, Garcea RL, Neu U, Stehle T. Structural and Functional Analysis of Murine Polyomavirus Capsid Proteins Establish the Determinants of Ligand Recognition and Pathogenicity. PLoS Pathog. 2015 Oct 16;11(10):e1005104. doi: 10.1371/journal.ppat.1005104. 

Hassett KJ, Meinerz NM, Semmelmann F, Cousins MC, Garcea RL, Randolph TW. Development of a highly thermostable, adjuvanted human papillomavirus vaccine. Eur J Pharm Biopharm. 2015 Aug;94:220-8. doi: 10.1016/j.ejpb.2015.05.009. Epub 2015 May 18.Â